NIH Biosketch available OnlineVinicio de Jesus Perez MD
- Instructor, Medicine - Pulmonary & Critical Care Med
Contact Information
- Clinical Offices
Pulmonary & Critical Care 300 Pasteur Dr H3142 MC 5236 Stanford, CA 94305 Telephone Work (650) 723-6381 Fax (650) 725-5489
- Academic Offices
Personal InformationAdministrative Contact Michelle Fox Administrative Assistant Email mfox1@stanford.edu Tel Work 1-650-723-5737Not for medical emergencies or patient use
Clinical Focus
- Pulmonary Disease
- Pulmonary Hypertension
Administrative Appointments
- Instructor, Stanford University , (2006– present )
- Postdoctoral Research Fellow-Rabinovitch Lab, Stanford University , (2004– 2008 )
Honors and Awards
- Member-at-large, Cardiopulmonary, Critical Care, Perioperative & Resuscitation Council, American Heart Association (2010-)
- Scholar, Harold Amos Career Development Award, Robert Wood Johnson Foundation (2010-2014)
- ATS travel award, ATS (2009)
- Finalist, BWF award, Burroughs Wellcome Fund (2009)
- 2008 Professional of the year, Madison Who's who among pofessionals in America (2009)
- Fellow, Pulmonary Vascular Research Institute (2008)
- Career Development Program in the Genetics and Genomics of Lung Diseases (K12), NIH (2008)
- AHA Scientific Sessions 2008 Best Basic Science Abstract, American Heart Association (2008)
- American Lung Association Career Development Award, American Lung Association (2008)
- Oak Foundation Grant, Oak Foundation (2008)
- AHA 2007 Junior Investigator Travel Award, American Heart Association (2007)
- ATS 2007 Travel award, American Thoracic Society (2007)
- Who's Who in America, Madison's Who's Who (2007)
- Finalist, Young Investigator Award, Stanford University Medical Center-Cardiovascular Institute (2007)
- Who's Who in Medicine in America 2007, Marquis Who's Who in America (2007)
- American Lung Association Postdoctoral Fellowship Award, American Lung Association (2006)
- Best Fellow, University of Colorado-Denver (2003)
- Best Intern in Medicine, Massachusetts General Hospital (2001)
- Most Promising Young Profesional 2000, El Nuevo Dia (2000)
- Summa cum Laude-Medicine, University of Puerto Rico (2000)
- Beta Beta Beta Award, Beta Beta Beta (1996)
- Summa cum Laude-Biology, University of Puerto Rico (1996)
Professional Education
- Board Certification: Critical Care Medicine, American Board of Internal Medicine (2007)
- Board Certification: Pulmonary Disease, American Board of Internal Medicine (2006)
- Massachusetts General Hospital/Joslin Diabetes Center (2003) MA
- Massachusetts General Hospital/Joslin Diabetes Center (2001) MA
- Stanford University Medical Center (2006) CA
- Univ Of Colorado (2004) CO
- Board Certification: Internal Medicine, American Board of Internal Medicine (2003)
- University Of Puerto Rico (2000) PR
- MD, Stanford University Pulmonary/CCM (2006)
- MD, University of Colorado-Denver Pulmonary/CCM (2004)
- MD, Massachussetts General Hospital Internal Medicine (2003)
- MD, University of Puerto Rico Medicine (2000)
- BS, University of Puerto Rico Biology (1996)
Graduate & Fellowship Program Affiliations
Community & International Work
- Pulmonary Vascular Research Institute More »
- North American Vascular Biology Society More »
- American College of Chest Physicians More »
- American Thoracic Society More »
- American Society of Cell Biology More »
- American Heart Association More »
- National PH Association More »
- Fraternity of Free and Accepted Masons-California Chapter, Palo Alto Roller Lodge More »
Web Site Links
Research Interests
My research work is aimed at understanding how the following processes impact the development of abnormal vascular remodeling in Pulmonary Hypertension:
1) Role of the Wnt signaling pathways in regulation of pulmonary angiogenesis: I am currently working with both in vitro and murine transgenic models to determine whether abnotmalities in both canonical and noncanonical Wnt pathways may impact the function of BMP signaling in pulmonary endothelial cells and affect development of pulmonary hypertension.
2) Role of Wnt signaling in smooth muscle growth and movement: I am using both in vitro and a tissue specific conditional SM22 transgenic mouse to explore the impact of BMPRII knockdown on SMC behavior and explore the role that both canonical and noncanonical Wnt signaling pathways play in this response. In addition, we want to explore how the immediate extracellular environment may contribute to increase the susceptibility of SMC to surrounding growth factors and promote their unrestricted growth.
3) Role of BMPRI and II haploinsufficiency in PAH: Using a novel tamoxifen-CRE murine model, we will explore the contribution that dual reduction in expression of BMPRIa and II have on development of PAH. This work will also be complemented by use of genomic and molecular approaches to identify novel gene targets for future studies.
Publications
- J Cell Biol. 2009; (1): 83-99
- Circ Res. 2009; (7): 639-47, 13 p following 647
- J Heart Lung Transplant. 2009; (5): 527-30
- J Cell Biochem. 2009; (2): 433-46
- J Clin Invest. 2008; (5): 1846-57
- Journal of Medical Case Reports. 2008; (2)
- Circulation. 2007; (10): 1275-84
- Circulation. 2006; (18): 83
- Circulation. 2006; (18): 37